close

Enter

Log in using OpenID

Idiopathic Hypertension Market Size, Symptoms, Treatment, Causes, Analysis and Pipeline Review, H1 2016

embed
Global Markets Direct's, 'Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016', provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Idiopathic (Essential) Hypertension Market Size, Symptoms,
Treatment, Causes, Analysis and Pipeline Review, H1 2016
Summary
Global Markets Direct's, 'Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016', provides an
overview of the Idiopathic (Essential) Hypertension pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Idiopathic
(Essential) Hypertension, complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and latest
news and press releases. Additionally, the report provides an overview of key players involved in
therapeutic development for Idiopathic (Essential) Hypertension and features dormant and discontinued
projects.
Browse Detail Report With TOC @ http://www.hexareports.com/report/idiopathic-essentialhypertension-pipeline-review-h1-2016/details
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic
review following a stringent set of processes to ensure that all the profiles are updated with the latest
Hexa Reports
Market Research Reports and Insightful Company Profiles
set of information. Additionally, various dynamic tracking processes ensure that the most recent
developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter strategies to gain
competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data.
Scope
- The report provides a snapshot of the global therapeutic landscape of Idiopathic (Essential)
Hypertension
- The report reviews pipeline therapeutics for Idiopathic (Essential) Hypertension by companies and
universities/research institutes based on information derived from company and industry-specific
sources
- The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved Idiopathic (Essential) Hypertension therapeutics and enlists all
their major and minor projects
- The report assesses Idiopathic (Essential) Hypertension therapeutics based on drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Idiopathic (Essential) Hypertension
Reasons To Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D
strategies
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Idiopathic
(Essential) Hypertension
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline
therapeutics
Hexa Reports
Market Research Reports and Insightful Company Profiles
- Devise corrective measures for pipeline projects by understanding Idiopathic (Essential) Hypertension
pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline
Request A Sample copy of This Report @ http://www.hexareports.com/sample/113823
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Idiopathic (Essential) Hypertension Overview 8
Therapeutics Development 9
Pipeline Products for Idiopathic (Essential) Hypertension - Overview 9
Idiopathic (Essential) Hypertension - Therapeutics under Development by Companies 10
Idiopathic (Essential) Hypertension - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Idiopathic (Essential) Hypertension - Products under Development by Companies 14
Idiopathic (Essential) Hypertension - Companies Involved in Therapeutics Development 15
Actelion Ltd 15
Bayer AG 16
Chong Kun Dang Pharmaceutical Corp. 17
Daiichi Sankyo Company, Limited 18
Eli Lilly and Company 19
HanAll Biopharma Co., Ltd. 20
Browse Full Report @ http://www.hexareports.com/report/idiopathic-essential-hypertension-pipelinereview-h1-2016/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in
1/--pages
Report inappropriate content